Zaremba Rabourn Amy 4

What Happened
Amy Zaremba Rabourn, Head of Financial Quality Assurance at Opus Genetics (IRD), had 3,390 shares withheld on 2026-01-18 to satisfy tax withholding obligations tied to a restricted stock unit (RSU) vesting/settlement. The withholding was reported at $2.10 per share, a notional value of $7,119. This was a tax-withholding disposal (transaction code F), not an open-market sale.

Key Details

• Transaction date and price: 2026-01-18 at $2.10 per share (3,390 shares; $7,119 total).
• Shares owned after transaction: not specified in the Form 4 filing.
• Footnote: Issuer withheld the shares to satisfy tax withholding obligations from an RSU vesting/settlement (not an open market sale).
• Filing timeliness: Report filed 2026-01-21 for a 2026-01-18 event — filed promptly (not marked late).
• Transaction type: F = tax withholding / share retention to cover taxes.

Context
This was a routine net settlement/tax-withholding related to RSU vesting, which reduces reported shares but does not indicate an open-market sale or necessarily reflect the insider’s view on the stock. For retail investors, purchases or open-market sales tend to be more informative about insider sentiment than tax-withholding disposals.